Imagination Spongebob
Patient reports improved creative problem-solving in their medical notes, which is either the cannabinoids or finally giving themselves permission to think differently. Either way, we’ll take the W. Further Reading Cannabis NewsRecreational drugs…
Hide the Pain Harold
When your patient asks if cannabis helps with their condition and you’re legally required to say “more research is needed” while they’re literally describing symptom relief. Further Reading Cannabis NewsRecreational drugs triple…
Ontario Labour Arbitration Highlights Cannabis Impairment Challenges
An Ontario labour arbitration decision highlights cannabis impairment workplace challenges. The ruling shows proving cannabis impairment is key in safety-sensitive roles. This case underscores the difficulty of detecting functional impairment versus mere…
Pres. Trump’s Executive Mandate Speeds DEA Licensing for Cannabis Research
DEA licensing cannabis research is accelerating due to recent executive actions. This change addresses longstanding regulatory delays that have hindered clinical investigation. The streamlined approval process is expected to expand research on cannabis…
Dabney: The Limits of Cannabis Impairment Testing
Cannabis impairment testing limitations are critical for clinicians to understand. Current breathalyzers and saliva tests detect cannabinoids but cannot reliably prove impairment. This gap affects patient counseling and legal interpretations.
Omagh Biotech Start-Up Boosts Research into Obesity and Epilepsy
Sonas Pharma’s funding boost advances endocannabinoid system obesity epilepsy research. This biotech aims to develop targeted therapeutics for these challenging conditions. The focus on endocannabinoid system obesity epilepsy offers hope for improved…
What to Know About How GLP-1 Medications Might Fight Addiction – The Washington Post
GLP-1 receptor agonist addiction treatment shows promise as a novel approach for substance use disorders. These medications, already used for metabolic diseases, may reduce cravings by affecting brain reward pathways. Ongoing research is crucial to…
Daily Digest: Last 19 Hours: Aging Brains, Adolescent Risk, and the Slow March of Policy Reform — March 04, 2026
This digest reviews recent findings on cannabis and cognitive aging, highlighting reassuring safety data for older adults. It also addresses adolescent cannabis exposure risks and ongoing policy reform challenges. The focus on cannabis and cognitive…
West Virginia House Approves Medical Cannabis Edibles Bill
West Virginia medical cannabis program expands to include edible formulations, offering patients improved access and treatment options. Edibles provide pharmacokinetic advantages for those with respiratory issues or needing longer symptom relief. This…
Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial
The CBD endometriosis trial backed by the NHS is entering its dosing phase, offering hope for better pain management. This trial focuses on cannabidiol's role in treating chronic pelvic pain associated with endometriosis. Access to clinical trial data…